Testing effectiveness (Phase 2)Study completedNCT00191711
What this trial is testing
Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.
Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 43